Envoy Medical Inc.
COCH | NASDAQ
$0.71
$0 (-0.55%)
At close: Sep 21, 2026, 4:00 PM ET
$0.72
+$0.01 (+2.07%)
Pre-market:
Sep 22, 2026, 9:15 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 241K | 225K | 316K | 237K | 310K | n/a |
Cost of Revenue | 874K | 742K | 789K | 498K | 769K | n/a |
Gross Profit | -633K | -517K | -473K | -261K | -459K | n/a |
Operating Income | -22.27M | -19.26M | -18.36M | -8.71M | -6.87M | -701 |
Interest Income | n/a | n/a | n/a | n/a | 37.67K | n/a |
Pretax Income | -23.76M | -20.8M | -29.92M | -15.92M | -8.68M | -701 |
Net Income | -23.76M | -20.8M | -29.92M | -15.92M | -8.68M | -701 |
Selling & General & Admin | 9.15M | 8.56M | 8.93M | 3.47M | 2.47M | 701 |
Research & Development | 12.49M | 10.18M | 8.96M | 4.98M | 3.94M | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 21.64M | 18.74M | 17.89M | 8.45M | 6.41M | 701 |
Interest Expense | 1.59M | 816K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 1.22M | 1.73M | 1.67M | 885K | n/a | n/a |
Cost & Expenses | 22.51M | 19.48M | 18.68M | 8.94M | 7.18M | 701 |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 23.26M | 18.79M | 12.55M | 10.15M | 10.15M | 60.38M |
Shares Outstanding (Diluted) | 23.26M | 18.79M | 12.55M | 10.15M | 10.15M | 60.38M |
EPS (Basic) | -1.23 | -1.49 | -2.54 | -1.57 | -1.05 | n/a |
EPS (Diluted) | -1.23 | -1.49 | -2.54 | -1.57 | -1.05 | n/a |
EBITDA | -21.86M | -19.81M | -29.79M | -15.85M | -8.6M | -701 |
EBIT | -22.17M | -19.98M | -29.92M | -15.92M | -8.68M | -701 |
Depreciation & Amortization | 302K | 173K | 133K | 75K | 71K | n/a |
Add to Watchlist
Select watchlists to add or remove COCH